In an interview, Stanford bioengineer Michael Fischbach discussed the growing knowledge of the bacteria in our bodies and what that means for the future of medicine.
Testing the side effects of every drug combination is impractical, but Stanford researchers think they have a better way: artificial intelligence.
Targeted screening can cut hepatitis B related deaths in the U.S. by half - and save money.
A new study shows that the process of turning a group of blood vessel cells into an artery actually requires that they stop growing.
A group of biodesign fellows developed a potential treatment for benign prostatic hyperplasia, an age-related condition that affects many men.
A new study examined the role of physician burnout in medical errors.
A group of researchers have developed an imaging method to show the brain in motion.
A diabetes program, developed with a Stanford scientist, helps cut costs of diabetes-related health care expenses by $815 per year per person.
Fanconi anemia inspired a collaboration between Stanford scientists to develop a method for detecting problematic molecules known as aldehydes.
Stanford neuroscientist Andrew Huberman is studying the effectiveness of virtual reality as a tool for preserving sight for glaucoma patients.
Researchers have made a molecular movie showing how retinal changes shape when hit by light. Retinal is critical to vision and many other light-driven processes.
Stanford's Karl Deisseroth has won the 2018 Kyoto Prize in applied technology for his invention and application of optogenetics.
Researchers at Stanford are harnessing sound and acoustics to innovate technologies that boost medical and health applications; from a stethoscope that "hears" brain waves, to software that identifies the hums of mosquitoes.
By studying how birds regrow damaged inner ear cells to fix hearing loss, scientists hope to learn how to cure deafness in humans.
A hitherto unheralded set of telltale enzymes may prove to be perfect targets for shooting down a gang of nasty bacterial pathogens collectively called S. aureus.
Blood cells to neurons in just three weeks? Stanford researchers pull off an amazing biological transformation that could transform research into neurological disorders such as schizophrenia and autism.
